戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ly diverse sparsely-distributed features may benefit from 3D-reconstruction.
2     We argue that SUD-related research would benefit from a 'bottom-up' approach including: (i) the c
3 optogenetics, the scientific community would benefit from a centralized database listing all attempts
4 und Detection of cerebral lesions at MRI may benefit from a chemically stable and more sensitively de
5 also suggest that future fMRI research could benefit from a closer examination of the correlational s
6  and procedures, resolving crises would also benefit from a deeper understanding of the concepts and
7     However, they remain empirical and would benefit from a detailed study of the physics controlling
8  higher risk of treatment resistance and may benefit from a dual HER3-EGFR inhibitor and a PARP1 inhi
9 gations of plant cell division would greatly benefit from a fast, inducible system.
10                           These applications benefit from a key feature of 2D materials, namely the l
11 t liver candidates awaiting transplant would benefit from a model employing continuous distribution a
12                 Tackling these problems will benefit from a more explicit and concerted effort to wor
13 design of functional enzyme models but might benefit from a paradigm shift related to recent findings
14 ivation, patients with a high MV score could benefit from a personalized antiplatelet therapy.
15                 These patients are likely to benefit from a range of interventions (eg, psychotherapy
16 est that the traditional cognitive model may benefit from a reformulation that takes current Bayesian
17 tunately, less than 2% of patients who could benefit from a sight-restoring corneal transplant have a
18  strong preclinical evidence of a predictive benefit from a specific therapy.
19 able preexisting anti-GBS concentrations may benefit from a sufficiently spaced second vaccine dose.
20 atterns of disease predisposition that might benefit from a targeted pharmacologic intervention.
21                          Responding patients benefited from a brief but intensive course of eculizuma
22 urban slum in Dhaka, Bangladesh, and had not benefited from a nutritional intervention, we performed
23          In summary, older patients with AML benefited from a reduced-intensity conditioning regimen
24                            The reaction also benefits from a Cu(OAc)(2) cocatalyst, and mechanistic s
25                                    (13)C NMR benefits from a larger signal dispersion but is barely u
26                                          EPA benefits from a precise signal recording and analysis me
27                                    This work benefits from a synthetic pathway that allows for the fa
28 inoma and may identify patients who may most benefit from AC.
29 ype 2 diabetes who may derive cardiovascular benefit from addition of this treatment to statins.
30 er incompletely recovered COPD exacerbations benefit from additional treatment with ciprofloxacin, at
31 epidemiologic and academic communities could benefit from adopting these goals and strategies within
32 val outcomes and identify subpopulations who benefit from adrenal metastasectomy.
33 edication-resistant tremor, and dyskinesias, benefit from advanced treatments such as therapy with le
34 allowing for a greater number of patients to benefit from advancements in genetic therapeutics.
35 on would enable identifying patients who may benefit from aggressive supportive care and early interv
36 rapy (AIT) study indicated that patients may benefit from AIT to different extents depending on their
37 rotein cholesterol (LDL-C) predicted greater benefit from alirocumab treatment.
38 known risk factors, who might derive greater benefit from alirocumab treatment.
39 the experienced environment, individuals may benefit from altering their social behaviours in a conte
40 that patients with SEMA7A(+)ER(+) tumors may benefit from alternative therapeutic strategies.
41 d biomarker, may identify patients who would benefit from alternative treatment strategies.
42 patients who do not respond to CRT and could benefit from alternative treatment.
43 highest level of distress and complexity may benefit from an admission to acute palliative care units
44 l proportion have refractory disease and may benefit from an alternate treatment.
45 hat future work on the POLS hypothesis would benefit from an approach integrating behaviour and life
46                  Cerebrovascular surgery can benefit from an intraoperative system that conducts cont
47  SCC and supports that patients with ADC may benefit from antifibrotic drugs targeting stromal TGFbet
48  we tested the idea that social learning can benefit from any available sensory cue, thereby permitti
49                                       Plants benefit from associations with a diverse community of ro
50  tumor ATM alterations may be more likely to benefit from ATR inhibitor than PARP inhibitor therapy.
51 ed patients who derived substantial survival benefit from BB exposure from a larger group that did no
52 ce showing that 60-80% of distressed couples benefit from behavioral and emotion-focused approaches t
53 5-2016, many individuals in the US who could benefit from being on PrEP were not receiving this HIV p
54 ussions during interprofessional team rounds benefit from being patient-centered and goal-oriented.
55 GluC, chymotrypsin, and proteinase K largely benefited from being paired with trypsin in sequential d
56 es of identifying patients that derive an OS benefit from bevacizumab.
57 inhibitor is one of many peptides that could benefit from bioactive cyclization, a strategy that is a
58 known about the host's actual role and if it benefits from biodegradation of this synthetic polymer.
59               Entrenched conflict appears to benefit from Bioethics Mediation, an approach that uses
60 derestimate the real costs and thus also the benefits from biological control.
61 efore, integral to identify patients who may benefit from biventricular support early post-LVAD impla
62                         Plant breeding would benefit from borrowing approaches found useful in other
63 (8:1 dr) and DE ring closures (14:1 dr) that benefit from both preorganization by the preformed AB ri
64 of sighted individuals whose color-knowledge benefits from both sensory experience and language.
65 uiding tool and push the limits of who might benefit from CAC in clinical practice.
66 e a significantly worse prognosis and do not benefit from chemotherapy, but the mechanisms underlying
67 ew suggests that Great Lakes sea lamprey may benefit from climate change with longer growing seasons,
68 iol PET uptake identified patients likely to benefit from combination therapy, but vorinostat did not
69                         These patients might benefit from combined and sequential targeted therapies.
70 for sensory feedback restoration can greatly benefit from computational models for simulation-based n
71 identification of individuals most likely to benefit from costimulation blockade.
72 ontrast, other proteins are predicted not to benefit from cotranslational folding due to a lack of si
73 Regardless of admission time, patients had a benefit from culprit-lesion-only as compared to immediat
74                           We found that ants benefited from cultivating plants in full sun, receiving
75 on of axonal structures as thin as one voxel benefits from data augmentation but also requires a loss
76 y associated with childhood maltreatment can benefit from deeper understanding of the subjective expe
77 robial communities have been widely shown to benefit from diatom excretions that accumulate within th
78 e permitted claims that promise vague health benefits from disease-specific claims reserved for drugs
79                                  Angiosperms benefit from diverse anatomical and physiological adapta
80 ion and the associated risk for falls do not benefit from dopamine replacement therapy and often resu
81 rkers to stratify patients who are likely to benefit from DPS, but instead used in conjunction with t
82 nder current screening guidelines, but might benefit from earlier screening.
83 ith a recessive inheritance pattern, who may benefit from early diagnosis and treatment.
84  and may help distinguish patients who would benefit from early intervention from those who may be re
85     These may identify individuals likely to benefit from early screening and specialized surveillanc
86 le conditions, while residents gain breeding benefits from early access to resources.
87  suggesting patients with hypoxic tumors may benefit from EGFR inhibitors already available in the cl
88 ts can help to identify individuals who will benefit from either CABG or PCI, thereby supporting hear
89 essential for identifying patients who might benefit from enasidenib therapy, including those patient
90 metastatic breast cancer with prior clinical benefit from endocrine therapy but later progression on
91 e standard for predicting which patients may benefit from endocrine therapy, and no other assays are
92  aqueous phase hydrogenation reactions which benefit from enhanced hydrogen solubility.
93 ructure is in place and there is an economic benefit from enhanced oil recovery.
94  patients at increased risk of death who may benefit from enhanced supportive care.
95 recipients at high risk for infections might benefit from enhanced surveillance or follow-up to mitig
96 tial number of lesions appear to continue to benefit from enzalutamide beyond progression.
97  low event rate and did not appear to derive benefit from evolocumab over 2.3 years.
98 d derived the greatest relative and absolute benefit from evolocumab, which mitigated this risk.
99 patients require lifelong monitoring and may benefit from expeditious assessment and intervention at
100 onstruction of deep-learning algorithms that benefit from expert knowledge and allow a biological und
101  be used to aid expert segmentation, but can benefit from expert supervision, particularly to resolve
102 tients with type 2 diabetes who would derive benefit from fenofibrate treatment, in addition to those
103 T/T homozygotes experienced a cardiovascular benefit from fibrate even in the absence of atherogenic
104   Obesity prevention efforts might therefore benefit from focusing on eating behavior change, particu
105 tion is modifiable; public health policy may benefit from focusing on reductions in environmental met
106  applications in evolutionary medicine would benefit from focusing on traits with correlations that a
107 ted in increasing environmental equality may benefit from framing such proposals as bestowing relativ
108 ts with sepsis and low acuity of illness may benefit from further work up before initiating therapy,
109 cenarios will stimulate Burgundy truffles to benefit from future warming.
110 hermore, we examine how medical research can benefit from genetic insights into social-scientific out
111      Cherry breeding and genetic studies can benefit from genome-wide genetic marker assays.
112 hat first responding individuals (those that benefit from group disorder) maintain larger differences
113  in health and disease is essential and will benefit from harnessing the right combination of advance
114 sciences, and food packaging, which can also benefit from having sustainable, nontoxic, and degradabl
115 ersons, regardless of their CVD risk status, benefit from healthy eating behaviors and appropriate ph
116 e by cancer type identified the most certain benefit from heparin treatment in patients with lung can
117 rement of LR in eradication strategies would benefit from high throughput and scalable assays.
118 fore, native mass spectrometry would greatly benefit from higher resolution approaches for intact pro
119 efore, assessment of nontechnical skills may benefit from holistic assessment of the collective surgi
120 Potential profiles of those who would likely benefit from IACS injection and a suggestion for an upda
121 dy also suggests that PBRM1 mutation reduces benefit from ICB.
122 ecular determinants associated with clinical benefit from ICI therapy.
123 n of patients with complex disease who would benefit from imaging of function and fibrosis in additio
124  and expand the spectrum of patients who can benefit from immune checkpoint blockade.
125 ors suggests that LRRK2 mutations may herald benefit from immune checkpoint inhibition.
126  disease subpopulations that exhibit greater benefit from immune checkpoint inhibitors, or by providi
127 re hot, and a limited proportion of patients benefit from immunotherapies.
128 paraclinical evidence suggestive of a likely benefit from immunotherapy.
129 mber of patients with cancer who are able to benefit from immunotherapy.
130 and high-income countries are more likely to benefit from improved availability of targeted therapy (
131                        Future research might benefit from improved imaging technology, and attention
132 particularly for Alzheimer's disease, it may benefit from incorporating the subjective experience of
133 s, thus tending to offset the climate change benefit from increased SOC storage.
134 ir epithelial antiproliferative response and benefit from increased TGFbeta expression and autocrine
135 DNAemia and biopsy-proven BKPyVAN, who would benefit from individualized therapeutic interventions su
136 xidants from food sources alone may confer a benefit from infections and mucositis during treatment o
137     Interestingly, their performance did not benefit from information feedback.
138      Thus, the traditional approach does not benefit from information potentially contained in any ad
139                                    We reveal benefits from information transfer about predators as a
140 o identify diseases and individuals that may benefit from inhibition or activation of NMD.
141 ntion and treatment of chronic diseases will benefit from insight into which population groups show g
142                 Studies of complex disorders benefit from integrative analyses of multiple omics data
143 inical outcomes upon infection, who may most benefit from intensive clinical interventions, in additi
144 ALCL PDX model showed a significant survival benefit from intermittent compared with continuous TKI d
145                                   The method benefits from known network edges and steady-state data
146  found that participants' memory performance benefited from learning this prior information.
147 d patients, even after remission, might also benefit from less commonly used treatments such as cogni
148 oy transmission amplitude gain, but may also benefit from less variability and shortened latencies at
149                                   Plants may benefit from limiting the community of generalist floral
150  advanced iCCA after neoadjuvant therapy may benefit from LT under research protocols.
151  and identify patient populations that would benefit from macrophage-targeted therapies.
152 ty-driven tools, which both are built by and benefit from many different people with different backgr
153 ss effects persisted, but the groups of fish benefiting from marine reserves profoundly changed, with
154 s are initiated by females, who gain fitness benefits from mating with extragroup males in the midst
155        However, because longer supply chains benefit from maximizing comparative advantage, this emis
156                            The likelihood of benefit from MET-targeted therapies increases with incre
157       Thus, these technologies would greatly benefit from methods to engineer arbitrary intensity sha
158 , (2) bioengineered tumor models, which have benefitted from microfluidics and mechanical engineering
159 d model that predicts trait-related survival benefits from mixed-species group formation in a multi-s
160 e-to-severe COVID-19 pneumonia are likely to benefit from moderate-dose corticosteroid treatment when
161  The assessment of model skill, in turn, can benefit from modern data science approaches.
162                 Patients undergoing ABMR may benefit from monitoring and therapeutic targeting of T(F
163 tal brain injury in a subset of ASD that may benefit from monocyte-targeted treatments.
164 omarkers that can identify patients who will benefit from monotherapy rather than from combinations.
165 omising for GWAS, but current approaches can benefit from more informative prior models.
166 sk groups and identifying patients who would benefit from more intensive treatment regimes.
167 ide with windows of higher excitability also benefit from more rapid and less variable corticospinal
168 ICGscore as a subgroup that may particularly benefit from multi-faceted immunotherapies, given their
169 o progress on gemcitabine-based regimens may benefit from multidrug immunotherapy.See related comment
170 his conclusion relies on the assumption that benefits from mutualisms never stop increasing.
171  are recent synthetic developments that have benefited from new structural biology data.
172 t treatment option for patients who have not benefited from or tolerated previous standard-of-care tr
173                   Most inferences on LD will benefit from our new findings, from point and interval e
174 A C-terminal frameshift mutations may derive benefit from p110alpha-selective inhibitors, including t
175  and women with heart failure derive similar benefit from palliative care interventions remains unkno
176                Thus, males might derive more benefits from parenting effort than mating effort as the
177 ion of patients with breast cancer likely to benefit from PARPi beyond gBRCA1/2 mutation carriers.
178 results, others have shown no clear survival benefit from particular combination treatments.
179  and identify individuals who derive greater benefit from PCSK9 (proprotein convertase subtilisin/kex
180 hich suggests that patients with sRCCs could benefit from PD1 and/or PDL1 immune checkpoint blockade
181 eded to identify which patients with LMD can benefit from pembrolizumab.
182 Patients with isolated mitral stenosis often benefit from percutaneous balloon mitral valvuloplasty.
183 ing method could help identify patients that benefit from PI3Kalpha inhibition and design drug combin
184          These households might additionally benefit from policies targeting unhealthy foods, such as
185 easible and identified individuals who could benefit from PrEP.
186 dentify high-risk individuals more likely to benefit from primary prevention statin therapy.
187                   Goal-directed behavior can benefit from proactive adjustments of cognitive control
188   Transcriptomics-based phenotype prediction benefits from proper normalization techniques and state-
189 ST is important to identify patients who may benefit from PZA treatment.
190     While UV/vis and fluorescence approaches benefit from readily available 96- and 384-well plate re
191                                Runners might benefit from reducing their HMP deviation and from selec
192 re, women who experienced preeclampsia might benefit from regular cardiovascular screening and interv
193  the neural basis of adaptive behavior could benefit from renewed experimental and theoretical invest
194 cute and chronic lung diseases would greatly benefit from reproducible availability of alveolar epith
195                                The cognitive benefit from rivastigmine is larger in patients with PDD
196  particularly among women who derive greater benefit from sacubitril/valsartan.
197 of the cancer: what subset of patients might benefit from second-line drugs, how to choose an optimal
198 ials might help identify individuals who can benefit from selenium supplementation, based, for instan
199 mas had durable tumor shrinkage and clinical benefit from selumetinib.
200                                              Benefiting from short reaction times, mild conditions, a
201 photonics but also for any platform that can benefit from simultaneously controlling visible light an
202 omozygous SMARCA4 missense mutations who may benefit from SMARCA2-targeted therapy.
203 etectable MRD after HCT derive the strongest benefit from sorafenib.
204  we detail scenarios in disease ecology that benefit from spatial-social analysis.
205 al squamous cell carcinoma (ESCC) who do not benefit from standard chemoradiation (CRT) is an importa
206 highlight areas that could have the greatest benefit from starting vaccination or from scaling up exi
207 ividuals at higher risk who derive increased benefit from statins.
208 uch patients is important to those who could benefit from strategies to maximize preventive measures.
209      According to our findings, Brazil would benefit from strategies to more accurately identify wome
210               Developmental biology has long benefited from studies of classic model organisms.
211 ene or a gene set is not significant, we may benefit from studying the relationships among genes in g
212        Patients who are HLA-A*01:01pos could benefit from such products, since no T cells recognizing
213 individuals may be most likely to derive net benefit from supplementation.
214 tients that currently has little therapeutic benefit from surgical treatment.
215                      Children with ALL would benefit from systematic revaccination postchemotherapy.
216 often based on Pd-catalyzed chemistry, would benefit from systems capable of delivering the catalyst
217 ble, sleep and public health researchers may benefit from taking a multilevel approach for addressing
218  the capabilities of human therapeutics that benefit from target clustering and higher-order antigen-
219  hospitalization rates and could potentially benefit from targeted clinical management strategies.
220 viduals at high risk of developing AML might benefit from targeted epigenetic therapy in a preventati
221 terms of hardening were identified who would benefit from targeted nicotine dependence intervention p
222  substantial long-term relapse-free survival benefit from targeted therapy (HR [versus placebo] 0.49,
223 stage III melanoma who might derive clinical benefit from targeted therapy.
224 ent study we tested whether older adults can benefit from task repetition in order to improve their p
225 ery campaigns focusing on SHP2 would greatly benefit from the ability to validate the cellular target
226 analysis, nonbasal patients seemed to derive benefit from the addition of capecitabine with a DFS HR
227  LGG regardless of codeletion status receive benefit from the addition of PCV.
228     However, the majority of patients do not benefit from the currently available immunotherapies and
229  people with impaired glucose tolerance, who benefit from the currently available lifestyle-based dia
230 ance of ruminant livestock has been shown to benefit from the enhanced nutritive value and herbage yi
231 hat did not act like enzymes but could still benefit from the enzymatic behaviour of other replicator
232 o recipients that are able to maximize their benefit from the full life of the organ.
233                                     Surgeons benefit from the improved visualization regardless of th
234  knockout (KO) and NOD2 KO organoids did not benefit from the MDP-induced cytoprotection.
235                          Females conceivably benefit from the mimetic pheromone during mate search bu
236 , besides whole kidney reconstruction, might benefit from the presence of LTbetaR signals.
237 mply that efforts to improve bee health will benefit from the promotion of high floral numbers to red
238            Furthermore, younger patients may benefit from the reduced radiation exposure of PET/MRI.
239 omplex signalling, especially in groups that benefit from the social transmission of alarm signals.
240 ensitivity and dynamic range of these assays benefit from the specificity of bioluminescent resonance
241  keratoplasty owing to corneal melting might benefit from the strengthening effect of preoperative CX
242 evels of Notch signaling, which would likely benefit from the use of Wnt signaling inhibitors.
243 as a heritable component, ME/CFS has not yet benefited from the advances in technology and analytical
244       Systemic mastocytosis (SM) has greatly benefited from the broad application of precision medici
245                         Peptide stapling has benefited from the development of several chemical react
246                     Thus, even if all groups benefited from the great expansion of free higher educat
247                     Ancient DNA research has benefited from the identification of skeletal elements,
248 de, numerous chemistry-oriented studies have benefited from the implementation of electronic modules,
249 iments revealed that the iron-based catalyst benefited from the propensity for beta-diketiminate liga
250 promoting the growth of some widespread taxa benefiting from the decline of phytoplankton blooms.
251 realism not possible in the laboratory while benefiting from the distinct capacity of camera traps to
252               Non-weighted MB-PLS1-DA models benefiting from the synergy between the two sources of d
253 spectrum, peptide, and protein levels, while benefiting from the theoretical guarantees of the Benjam
254                                              Benefiting from the unique host-guest interaction (e.g.,
255 mental research radiotracers illustrated the benefits from the combination of large axial coverage an
256 features of the projection neuron responses, benefits from the nonlinearity in the transfer function,
257 indicating that display uniformity judgments benefitted from the emergent features of Diamonds.
258                                              Benefitting from the above, the overall electrochemical
259 uppress the amorphous silica-derived signal, benefitting from the extremely long T(2) relaxation time
260                                              Benefitting from the pH-responsiveness of WP5, the bindi
261 g scheme means that many more people seek to benefit from their very generous donation.
262                                              Benefiting from their superior chemical and physical sta
263 posed to multiple DMARDs without necessarily benefitting from them; a group of patients variously des
264 f new therapies for cystic fibrosis (CF) has benefited from therapeutically responsive biomarkers to
265  cardio-inflammatory phenotype and will thus benefit from therapies targeting inflammation.
266  that some patients do not derive sufficient benefit from these additional therapies to offset the as
267     Patients with CKD are uniquely poised to benefit from these integrative, multi-omics approaches s
268 ts at risk for falling out of care who would benefit from these interventions.
269 ope that both newcomers and specialists will benefit from these recommendations to increase the inter
270 ervous system and other organs can similarly benefit from these technologies.
271  factors to identify subjects most likely to benefit from these therapies.
272                                              Benefited from these, the modified Li-rich electrode exh
273              This review describes platforms benefiting from these cytosensors to identify cancerous
274 al tests of nature in higher dimensions will benefit from this approach.
275 h swipes across many application areas could benefit from this convenient approach, including the use
276  the mechanisms of HSC clonal evolution will benefit from this new approach to identifying informativ
277      Other tissue structures in the body may benefit from this new three dimensional approach.
278  and genetic disease prediction will greatly benefit from this resource.
279                       While there are ocular benefits from this diet trend, the potential for nutriti
280 ients with large vessel occlusions (LVO) can benefit from thrombectomy up to 24 hours after onset.
281 their patients' achievement of health status benefits from TMVr, with patient's baseline health statu
282 is important to identify individuals who may benefit from treatment beyond progression.
283 ps, whether the Haemophilus-high group might benefit from treatment strategies to modulate the airway
284 s, independent of tumor histology, who would benefit from treatment with a MAP kinase pathway inhibit
285 ntreated metastatic urothelial carcinoma who benefit from treatment with immune checkpoint inhibitors
286 ncers as a novel subgroup of tumors that may benefit from treatment with PI3K inhibitors and antiestr
287 s a pervasive respiratory disease that could benefit from treatments that augment immunity.
288                                 Thus, AD may benefit from TREM2 activation.
289                          Formazanate ligands benefit from tunable properties via structural variation
290 atients with cholestatic liver disease might benefit from UDCA with respect to periodontal health.
291 g pulmonary embolism may derive the greatest benefit from ultrasound-assisted, catheter-directed thro
292  Research in these fields, and others, would benefit from understanding the extent to which pleiotrop
293                                Surgeons will benefit from understanding the latest discoveries in neu
294 ign of efficient sugar-baited traps will all benefit from understanding the molecular basis of nectar
295 ecific areas of immunology research that may benefit from using animals with robust and varied microb
296 ly, we propose that RNA ligand discovery can benefit from using progress made within these three fram
297 he firmness and consistency of the doughnuts benefited from using natural colorants in the icing solu
298 RS-CoV-2 infection or COVID-19 disease would benefit from validated small animal models.
299 th adverse genetic markers had the strongest benefit from VenG, particularly subjects with unmutated
300 tors of reading abilities and the ability to benefit from visual speech to represent the syllabic con

 
Page Top